Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases - 26/08/11
Abstract |
Background |
The incidence of residual occult disease in nonsentinel lymph nodes (NSLN) after a positive sentinel lymph node (SLN) biopsy in patients with melanoma is relatively low. The purpose of this study is to identify factors that may be predictive of occult NSLN metastases after positive SLN biopsy.
Methods |
Fifty-six consecutive melanoma patients with positive sentinel nodes who subsequently underwent complete lymph node dissection (CLND) were evaluated.
Results |
Only the number of positive SLN predicted the status on NSLN by univariate (P = 0.008) and multivariate (P = 0.028) analyses. None of the other variables (characteristics of SLN metastases, number of draining nodal basins, age, sex, thickness, Clark level, ulceration, number of mitoses/mm2, histological subtype, and location of the primary) significantly predicted CLND results.
Conclusions |
Identifying patients with residual lymph node basin disease remains difficult. Thus, lymph node dissection should be performed in all patients after positive sentinel node biopsy.
Le texte complet de cet article est disponible en PDF.Keywords : Melanoma, Sentinel lymph node, Lymph node dissection, Nonsentinel lymph node
Plan
Vol 186 - N° 2
P. 98-101 - août 2003 Retour au numéro
Article précédent
- Trauma care and the “lethality perspective”
- J.David Richardson
- Sentinel node biopsy prior to neoadjuvant chemotherapy
- Michael S Sabel, Anne F Schott, Celina G Kleer, Sofia Merajver, Vincent M Cimmino, Kathleen M Diehl, Daniel F Hayes, Alfred E Chang, Lori J Pierce
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?